I think MTE is now worth monitoring.The selling is either totally exhausted, or just about.Bids will start to test higher, to see if they can draw out any more stock.The reaction to those tests is worth watching.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%